Title |
Topic 277, Developing BH3 Profiling as a Companion Diagnostic for Velcade Treatme
|
Institution |
EUTROPICS PHARMACEUTICALS, INC., CAMBRIDGE, MA
|
Principal Investigator |
CARDONE, MICHAEL
|
NCI Program Director |
N/A
|
Cancer Activity |
N/A
|
Division |
N/A
|
Funded Amount |
$1,499,746
|
Project Dates |
09/28/2012 - 09/27/2014
|
Fiscal Year |
2012
|
Project Type |
Contract
|
Research Topics w/ Percent Relevance |
Cancer Types w/ Percent Relevance |
Cancer (100.0%)
|
Multiple Myeloma (100.0%)
|
Research Type |
Technology and/or Marker Evaluation With Respect to Fundamental Parameters of Method
|
Abstract |
No abstract available. |